Literature DB >> 12417062

The role of fibroblast growth factor-2 in the vascularization of the chick embryo chorioallantoic membrane.

D Ribatti1, M Presta.   

Abstract

The CAM is an extraembryonic membrane which serves as a gas exchange surface and its respiratory function is provided by an extensive capillary network. The development of the vascular system of the CAM is a complex, highly regulated process that depends on genetic and epigenetic factors expressed by endothelial and non-endothelial cells. In spite of the evidence that several growth factors are angiogenic in the CAM assay, poorly investigated is their role in the development of the CAM's vascular system. This article reviews our studies concerning the role of exogenous and endogenous fibroblast growth factor-2 (FGF-2) in the CAM vascularization. The findings in all these studies support the importance of FGF-2 as an autocrine paracrine stimulator of angiogenesis and its key role in the development of the vascular system in the avian embryo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417062      PMCID: PMC6740312          DOI: 10.1111/j.1582-4934.2002.tb00524.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  9 in total

1.  45S5-Bioglass(®)-based 3D-scaffolds seeded with human adipose tissue-derived stem cells induce in vivo vascularization in the CAM angiogenesis assay.

Authors:  Marina Handel; Timo R Hammer; Patcharakamon Nooeaid; Aldo R Boccaccini; Dirk Hoefer
Journal:  Tissue Eng Part A       Date:  2013-08-12       Impact factor: 3.845

2.  Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway.

Authors:  Veronica C Ardi; Philippe E Van den Steen; Ghislain Opdenakker; Bernhard Schweighofer; Elena I Deryugina; James P Quigley
Journal:  J Biol Chem       Date:  2009-07-16       Impact factor: 5.157

Review 3.  Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions.

Authors:  Elena I Deryugina; James P Quigley
Journal:  Biochim Biophys Acta       Date:  2009-10-02

Review 4.  Pathophysiology of tumor neovascularization.

Authors:  Mitsuko Furuya; Mariko Nishiyama; Yoshitoshi Kasuya; Sadao Kimura; Hiroshi Ishikura
Journal:  Vasc Health Risk Manag       Date:  2005

5.  MMPs and angiogenesis affect the metastatic potential of a human vulvar leiomyosarcoma cell line.

Authors:  Carlotta Alias; Laura Rocchi; Domenico Ribatti; Stefano Caraffi; Alessandra D'Angelo; Roberto Perris; Domenica Mangieri
Journal:  J Cell Mol Med       Date:  2015-05-22       Impact factor: 5.310

6.  In ovo administration of human recombinant leptin shows dose dependent angiogenic effect on chicken chorioallantoic membrane.

Authors:  Reji Manjunathan; Malathi Ragunathan
Journal:  Biol Res       Date:  2015-06-10       Impact factor: 5.612

Review 7.  Nanocomposite scaffolds for accelerating chronic wound healing by enhancing angiogenesis.

Authors:  Hamed Nosrati; Reza Aramideh Khouy; Ali Nosrati; Mohammad Khodaei; Mehdi Banitalebi-Dehkordi; Korosh Ashrafi-Dehkordi; Samira Sanami; Zohreh Alizadeh
Journal:  J Nanobiotechnology       Date:  2021-01-04       Impact factor: 10.435

8.  Proangiogenic Effect of 2A-Peptide Based Multicistronic Recombinant Constructs Encoding VEGF and FGF2 Growth Factors.

Authors:  Dilara Z Gatina; Ekaterina E Garanina; Margarita N Zhuravleva; Gulnaz E Synbulatova; Adelya F Mullakhmetova; Valeriya V Solovyeva; Andrey P Kiyasov; Catrin S Rutland; Albert A Rizvanov; Ilnur I Salafutdinov
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

9.  Carbon nanoparticles downregulate expression of basic fibroblast growth factor in the heart during embryogenesis.

Authors:  Mateusz Wierzbicki; Ewa Sawosz; Marta Grodzik; Anna Hotowy; Marta Prasek; Sławomir Jaworski; Filip Sawosz; André Chwalibog
Journal:  Int J Nanomedicine       Date:  2013-09-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.